Login / Signup

The Diagnosis of Intestinal Fibrosis in Crohn's Disease-Present and Future.

Sara Jarmakiewicz-CzajaJolanta GruszeckaRafał Filip
Published in: International journal of molecular sciences (2024)
Crohn's disease (CD) progresses with periods of remission and exacerbations. During exacerbations, chronic inflammation leads to tissue destruction. As a result, intestinal fibrosis may develop in response to the ongoing inflammatory process. Fibrosis in CD should be considered the result of the response of the intestinal wall (over) to the presence of inflammation in the deep structures of the intestinal wall. In the absence of ideal noninvasive methods, endoscopic evaluation in combination with biopsy, histopathological analysis, stool analysis, and blood analysis remains the gold standard for assessing both inflammation and fibrosis in CD. On the contrary, the ability to identify markers of intestinal fibrosis would help to develop new diagnostic and therapeutic methods to detect early stages of fibrosis. It is speculated that miRNAs may, in the future, become biomarkers for early noninvasive diagnosis in the treatment of intestinal fibrosis. The purpose of this review is to summarise existing diagnostic methods for Crohn's disease and present recent scientific reports on molecular testing.
Keyphrases
  • oxidative stress
  • chronic obstructive pulmonary disease
  • cystic fibrosis
  • liver fibrosis
  • emergency department
  • ultrasound guided
  • high resolution
  • single molecule